title: Albendazole versus praziquantel for neurocysticercosis.
authors.affiliation: Clinical Economics Research Unit, Georgetown University Medical Center, Washington, DC, USA.
authors.forename: S S
authors.initials: SS
authors.lastname: Mehta
authors.forename: S
authors.initials: S
authors.lastname: Hatfield
authors.forename: L
authors.initials: L
authors.lastname: Jessen
authors.forename: D
authors.initials: D
authors.lastname: Vogel
mesh_terms: D015766:Albendazole / Q000627:therapeutic use*; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use*; D000980:Antiplatyhelmintic Agents / Q000627:therapeutic use*; D003551:Cysticercosis / Q000188:drug therapy*; D003552:Cysticercus; D004660:Encephalitis / Q000188:drug therapy* / Q000469:parasitology; D006801:Humans; D011223:Praziquantel / Q000627:therapeutic use*
chemical_list: D000871:Anthelmintics; D000980:Antiplatyhelmintic Agents; D011223:Praziquantel; D015766:Albendazole